Innovative Eyewear Inc. (LUCY) Financial Statements (2024 and earlier)

Company Profile

Business Address 11900 BISCAYNE BLVD
MIAMI, FL 33181
State of Incorp. FL
Fiscal Year End December 31
Industry (SIC) 3851 - Ophthalmic Goods (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,6494,2875,8537,3063,4503,591
Cash and cash equivalents2,6494,2873,9045,3563,4503,591
Short-term investments   1,9491,949  
Receivables5393128131128110
Inventory, net of allowances, customer advances and progress billings85953377666074395
Inventory85953377666074395
Prepaid expense426314290271185211
Other current assets595952363636
Other undisclosed current assets65330402367 198
Total current assets:4,1115,6177,5018,7704,5424,241
Noncurrent Assets
Property, plant and equipment143133178125138120
Intangible assets, net (including goodwill)330286272251240138
Intangible assets, net (excluding goodwill)330286272251240138
Other noncurrent assets1187354838382
Other undisclosed noncurrent assets 110110110110110110
Total noncurrent assets:702602615569571449
TOTAL ASSETS:4,8136,2198,1169,3405,1134,690
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:841582186149292276
Other undisclosed accounts payable and accrued liabilities841582186149292276
Deferred revenue434343303030
Debt      61
Other undisclosed current liabilities  202152182233
Total current liabilities:883624431331505600
Noncurrent Liabilities
Liabilities, other than long-term debt283543585865
Deferred revenue283543585865
Total noncurrent liabilities:283543585865
Total liabilities:911660474389563665
Equity
Equity, attributable to parent3,9025,5597,6428,9514,5504,024
Common stock000000
Additional paid in capital22,84222,52822,21821,97616,28714,330
Accumulated deficit(18,941)(16,969)(14,576)(13,025)(11,737)(10,306)
Total equity:3,9025,5597,6428,9514,5504,024
TOTAL LIABILITIES AND EQUITY:4,8136,2198,1169,3405,1134,690

Income Statement (P&L) ($ in thousands)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
Revenues38361622217014567
Cost of revenue(377)(796)(142)(200)(135)(264)
Gross profit:7(180)80(30)10(197)
Operating expenses(2,022)(2,315)(1,677)(1,304)(1,439)(1,680)
Operating loss:(2,015)(2,496)(1,597)(1,334)(1,429)(1,876)
Nonoperating income (expense)431024646(2) 
Other nonoperating income4310246480 
Interest and debt expense    (1)(2)(4)
Other undisclosed income from continuing operations before equity method investments, income taxes      104
Loss from continuing operations:(1,971)(2,394)(1,551)(1,289)(1,433)(1,776)
Other undisclosed net income (loss)    12(101)
Net loss attributable to parent:(1,971)(2,394)(1,551)(1,288)(1,431)(1,877)
Other undisclosed net loss available to common stockholders, basic      (7,609)
Net loss available to common stockholders, diluted:(1,971)(2,394)(1,551)(1,288)(1,431)(9,487)

Comprehensive Income ($ in thousands)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
Net loss:(1,971)(2,394)(1,551)(1,288)(1,431)(1,877)
Comprehensive loss, net of tax, attributable to parent:(1,971)(2,394)(1,551)(1,288)(1,431)(1,877)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: